BRTX
BioRestorative Therapies Inc

3,738
Mkt Cap
$4.94M
Volume
3.96M
52W High
$2.10
52W Low
$0.19
PE Ratio
-0.15
BRTX Fundamentals
Price
$0.2284
Prev Close
$0.2314
Open
$0.2191
50D MA
$0.9178
Beta
1.40
Avg. Volume
22,986.10
EPS (Annual)
-$1.16
P/B
0.83
Rev/Employee
$36,454.54
$0.3838
Loading...
Loading...
News
all
press releases
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9% - Here's Why
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9% - What's Next...
MarketBeat·17d ago
News Placeholder
More News
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 2.6% - Here's Why
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 2.6% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 1.8% - Should You Sell?
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Down 1.8% - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 2.7% - Time to Sell?
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 2.7% - Here's Why...
MarketBeat·3mo ago
News Placeholder
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Up 6.4% - What's Next?
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Up 6.4% - Here's What Happened...
MarketBeat·3mo ago
News Placeholder
Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of 0.00% and -97.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Earnings Outlook For BioRestorative Therapies
read more...
Benzinga·4mo ago
News Placeholder
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +11.36% and -86.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year?
Here is how Black Diamond (BDTX) and Biorestorative Therapies, Inc. (BRTX) have performed compared to their sector so far this year.
Zacks·7mo ago
News Placeholder
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of +26.83% and +51.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7mo ago
<
1
2
...
>

Latest BRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.